The #FDA released a statement today ALERTING laboratory personnel and healthcare providers about #Illumina cybersecurity vulnerabilities. Illumina supplies the majority of genomic laboratories with instrumentation to sequence DNA. The letter to healthcare providers discusses that a user may operate the technology for both clinical diagnostic use or research purposes. Ultimately the following is the most important information presented:
taking control of the instrument remotely;operating the system to alter settings, configurations, software, or data on the instrument or a customer’s network; orimpacting patient test results in the instruments intended for clinical diagnosis, including causing the instruments to provide no results or incorrect results, altered results, or a potential data breach.
#CenterForGenomicInterpretation appreciates the #FDA staying on top of cybersecurity events that could impact patient test results.
Labs should contact Illumina, if they didn’t receive a notification for a temporary patch until a permanent fix is found. techsupport@illumina.com
The post Illumina Cybersecurity Vulnerability May Present Risks for Patient Results and Customer Networks appeared first on Center for Genomic Interpretation.
The #FDA released a statement today ALERTING laboratory personnel and healthcare providers about #Illumina cybersecurity vulnerabilities. Illumina supplies the majority of genomic laboratories with instrumentation to sequence DNA. The letter to healthcare providers discusses that a user may operate the technology for both clinical diagnostic use or research purposes. Ultimately the following is the most
The post Illumina Cybersecurity Vulnerability May Present Risks for Patient Results and Customer Networks appeared first on Center for Genomic Interpretation.